Boardroom Alpha
Meeting calendar
SRRK · Annual meeting · Thursday, June 4, 2026

Scholar Rock Holding Corp

4 nominees · 3 ballot items.

Elect four Class II directors; ratify appointment of Deloitte & Touche LLP as independent auditor; approve, on a non-binding advisory basis, the compensation of the named executive officers (Say-on-Pay).

Market cap
$6.3B
1Y TSR
+39.5%
Board grade
C-
Record date
Apr 10, 2026
Filing
DEF 14A
Meeting concluded · Jun 4, 2026

Follow how the vote landed and what changed on Scholar Rock Holding Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Class II Directors

    ManagementBoard: FOR

    Elect four Class II directors (David Hallal, Kristina Burow, Michael Gilman, Ph.D., and Katie Peng) to serve three-year terms until the 2029 Annual Meeting.

  2. 2

    Ratification of the Appointment of Deloitte & Touche LLP as Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the audit committee’s appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.

    More detail

    This management proposal asks shareholders to ratify the audit committee’s selection of Deloitte & Touche LLP as the company’s independent registered public accounting firm for fiscal year 2026. Management frames this as a corporate governance practice—seeking shareholder affirmation of an auditor appointment that the audit committee previously approved following Ernst & Young’s decision not to stand for re-election. The proposal notes Deloitte was engaged on June 3, 2025 and that shareholder approval is not legally required but would signal support; if shareholders do not ratify, the audit committee would reconsider the appointment. The filing provides background on prior auditor transition, fees paid to Deloitte and Ernst & Young for recent years, and confirms no reportable disagreements or consultations that would raise independence concerns. Vote required is a majority of votes properly cast; the Board recommends a “FOR” vote, citing governance and oversight rationale.

  3. 3

    Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal requests an advisory approval of the company's executive compensation program as disclosed in the proxy statement (a Say-on-Pay vote). Management positions the vote as non-binding but important for receiving shareholder feedback that the Board and compensation committee will consider when making future compensation decisions. The filing describes the components of executive pay—base salary, annual cash incentive, and long-term equity including performance-based restricted stock units tied to stock-price targets—and explains how these elements are intended to align executive incentives with stockholder interests and retention goals. The filing notes peer benchmarking, use of an independent compensation consultant, severance and change-in-control protections, and compensation recovery policies. The Board recommends a “FOR” vote. The vote requires a majority of votes properly cast and is considered a non-routine matter for broker voting purposes.

Director elections

Nominees on the ballot4

Not independent
Tenure on this board
9.1 yrs
Also a director at
Kalaris Therapeutics Inc (KLRS)
Independent
Tenure on this board
12.0 yrs
Also a director at
Neumora Therapeutics Inc (NMRA)
Independent
Tenure on this board
2.4 yrs
Also a director at
Adicet Bio Inc (ACET)
Ownership

Top institutional holders10

Latest 13F quarter
1FMR LLC9.2%11,042,051$543M
2Siren, L.L.C.9.0%10,825,013$532M
3Redmile Group, LLC7.6%9,066,621$446M
4Samsara BioCapital, LLC5.8%6,897,652$339M
5PRICE T ROWE ASSOCIATES INC /MD/5.1%6,088,142$299M
6FMR LLC5.0%6,014,916$296M
7WELLINGTON MANAGEMENT GROUP LLP4.9%5,880,753$289M
8Orbis Allan Gray Ltd3.5%4,174,718$205M
9STATE STREET CORP3.4%4,031,317$198M
10VANGUARD CAPITAL MANAGEMENT LLC3.2%3,891,347$191M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Scholar Rock Holding Corp 2026 annual meeting?
Scholar Rock Holding Corp (SRRK) holds its 2026 annual shareholder meeting on Thursday, June 4, 2026.
What is the record date for the Scholar Rock Holding Corp 2026 meeting?
The record date for the Scholar Rock Holding Corp 2026 meeting is Friday, April 10, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Scholar Rock Holding Corp's 2026 meeting?
The board is presenting 4 director nominees at the Scholar Rock Holding Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Scholar Rock Holding Corp 2026 meeting?
Shareholders will vote on 3 proposals at the Scholar Rock Holding Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer